{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:51:23Z","timestamp":1756385483311},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1007\/s00105-006-1223-7","type":"journal-article","created":{"date-parts":[[2006,10,11]],"date-time":"2006-10-11T17:54:42Z","timestamp":1160589282000},"page":"988-993","source":"Crossref","is-referenced-by-count":4,"title":["HIV-assoziierte Tumore"],"prefix":"10.1007","volume":"57","author":[{"given":"A.","family":"Potthoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. H.","family":"Brockmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1223_CR1","unstructured":"Altmeyer P, Bacherach-Buhles M (2002) Enzyklop\u00e4die Dermatologie, Allergologie, Umweltmedizin. Springer, Berlin Heidelberg New York Tokyo, S 788\u2013792"},{"key":"1223_CR2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/cncr.20354","volume":"101","author":"Bonnet","year":"2004","unstructured":"Bonnet F, Lewden C, May T et al. (2004) Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 101: 317\u2013324","journal-title":"Cancer"},{"key":"1223_CR3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00002030-200302140-00011","volume":"17","author":"Bower","year":"2003","unstructured":"Bower M, Powles T, Nelson M et al. (2003) HIV-related lung cancer in the era of highly active antiretroviral therapy. AIDS 17: 371\u2013375","journal-title":"AIDS"},{"key":"1223_CR4","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1097\/00002030-200311070-00002","volume":"17","author":"Brau","year":"2003","unstructured":"Brau N (2003) Update on chronic hepatitis C in HIV\/HCV coinfected patients: viral interactions and therapy. AIDS 17: 2279\u20132290","journal-title":"AIDS"},{"key":"1223_CR5","first-page":"127","volume":"3","author":"Brockmeyer","year":"1998","unstructured":"Brockmeyer NH, Barthel B (1998) Clinical manifestations and therapies of AIDS associated tumors. Eur J Med Res 3: 127\u2013147","journal-title":"Eur J Med Res"},{"key":"1223_CR6","first-page":"95","volume":"4","author":"Brockmeyer","year":"1999","unstructured":"Brockmeyer NH, Willers CP, Anders S et al. (1999) Cytokine profile of HIV-positive Kaposi\u2019s sarcoma derived cells in vitro. Eur J Med Res 4: 95\u2013100","journal-title":"Eur J Med Res"},{"key":"1223_CR7","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.285.13.1736","volume":"285","author":"Frisch","year":"2001","unstructured":"Frisch M, Biggar RJ, Engels EA et al. (2001) Associaton of cancer with AIDS-related immunosuppression in adults. JAMA 285: 1736\u20131745","journal-title":"JAMA"},{"key":"1223_CR8","first-page":"987","volume":"54","author":"Gabizon","year":"1994","unstructured":"Gabizon A, Catane R, Uziely B et al. (1994) Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 54: 987\u2013992","journal-title":"Cancer Res"},{"key":"1223_CR9","first-page":"507","volume":"16","author":"Goebel","year":"1999","unstructured":"Goebel FD, Jablonowski H (1999) Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi\u2019s sarcoma-official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection. October 23, 1999 in Lisbon, Portugal. Eur J Res 16(4): 507\u2013513","journal-title":"Eur J Res"},{"key":"1223_CR10","unstructured":"Hoffmann C, Kamps BS (2004) HIV.NET 2005. Steinh\u00e4user, Wuppertal"},{"key":"1223_CR11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/028418600430789","volume":"39","author":"Koukourakis","year":"2000","unstructured":"Koukourakis M, Giatromanolaki A, Koukouraki S et al. (2000) High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas. Rationale for combination with radiotherapy. Acta Oncologica 39: 207\u2013211","journal-title":"Acta Oncologica"},{"key":"1223_CR12","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1055\/s-2003-42360","volume":"128","author":"Kreuter","year":"2003","unstructured":"Kreuter A, Reimann G, Esser S et al. (2003) Screening und Therapie der analen intraepithelialen Neoplasie (AIN) und des Analkarzinoms bei HIV-Infektion. DMW 128: 1957\u20131962","journal-title":"DMW"},{"key":"1223_CR13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jaad.2004.11.026","volume":"52","author":"Kreuter","year":"2005","unstructured":"Kreuter A, Brockmeyer NH, Hochdorfer B et al. (2005) Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection. J Am Acad Dermatol 52: 603\u2013608","journal-title":"J Am Acad Dermatol"},{"key":"1223_CR14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/107999002753675712","volume":"22","author":"Krown","year":"2002","unstructured":"Krown SE, Li P, Von Roenn JH et al. (2002) Efficacy of low-dose interferon with antiretroviral therapy in Kaposi\u2019s sarcoma: a randomized phase II AIDS clinical trials group study. J Interferon Cytokine Res 22: 295\u2013303","journal-title":"J Interferon Cytokine Res"},{"key":"1223_CR15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s15010-005-4099-z","volume":"33","author":"Lichterfeld","year":"2004","unstructured":"Lichterfeld M, Qurishi N, Hoffmann C et al. (2004) Treatment of HIV-1-associated Kaposi\u2019s sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery. Infection 33: 140\u2013147","journal-title":"Infection"},{"key":"1223_CR16","unstructured":"Maserati R et al. (2000) Effects of HAART regimen as exclusive treatment of slow proliferating Kaposi\u2019s sarcoma, 13th IAC, 2000, Abs TuOrB302"},{"key":"1223_CR17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1081\/CNV-100104284","volume":"19","author":"Osoba","year":"2001","unstructured":"Osoba D, Northfelt DW, Budd DW, Himmelberger D (2001) Effect of treatment on health-related quality of life in acquired immunodeficiency syndrom (AIDS)-related Kaposi\u2019s sarcoma: a randomized trial of pegylated liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine. Cancer Invest 19: 573\u2013580","journal-title":"Cancer Invest"},{"key":"1223_CR18","first-page":"710","volume":"30","author":"Powles","year":"2003","unstructured":"Powles T, Thirwell C, Newsom-Divis T et al. (2003) HIV adversely influence the outcome in advanced non-small cell lung cancer in the era of HAART. Br J Cancer 30: 710\u2013718","journal-title":"Br J Cancer"},{"key":"1223_CR19","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/sj.bjc.6601762","volume":"90","author":"Powles","year":"2004","unstructured":"Powles T, Bower M, Shamash J et al. (2004) Outcome of patients with HIV-related germ cell tumours: a case-control study. Br J Cancer 90: 1526\u20131530","journal-title":"Br J Cancer"},{"key":"1223_CR20","first-page":"444","volume":"89","author":"Rasokat","year":"1989","unstructured":"Rasokat H, Haussermann L, Minnemann M (1989) Response of AIDS-related Kaposi\u2019s sarcoma to treatment with recombinant interferon alpha depends on the stage of underlying immunodeficiency. J Invest Dermatol 89: 444\u2013445","journal-title":"J Invest Dermatol"},{"key":"1223_CR21","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/00002030-200308150-00009","volume":"17","author":"Rosenthal","year":"2003","unstructured":"Rosenthal E, Poiree M, Pradier C et al. (2003) Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS 17: 1803\u20131809","journal-title":"AIDS"},{"key":"1223_CR22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00000421-200202000-00012","volume":"25","author":"Rosenthal","year":"2002","unstructured":"Rosenthal E, Poizot-Martin I, Saint-Marc et al. (2002) Phase IV study of liposomal daunorubicin in AIDS-related Kaposi\u2019s sarcoma. Am J Clin Oncol 25: 57\u201359","journal-title":"Am J Clin Oncol"},{"key":"1223_CR23","first-page":"492","volume":"42","author":"Sch","year":"1991","unstructured":"Sch\u00f6fer H, Ochsendorf FR, Hochscheid I, Mulbradt R (1991) Kaposi-Sarkome im Gesicht: Palliative Behandlung mit Kryochirurgie, intral\u00e4sionaler Chemotherapie, R\u00f6ntgenweichstrahltherapie und Camouflage. Hautarzt 42: 492\u2013498","journal-title":"Hautarzt"},{"key":"1223_CR24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nm0302-225","volume":"8","author":"Sgadari","year":"2002","unstructured":"Sgadari C, Barillari G, Toschi E et al. (2002) HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi\u2019s sarcoma. Nat Med 8: 225\u2013232","journal-title":"Nat Med"},{"key":"1223_CR25","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0360-3016(93)90523-X","volume":"27","author":"Stelzer","year":"1993","unstructured":"Stelzer KJ, Griffin TW (1993) A randomized prospective trial of radiation therapy for AIDS-associated Kaposi\u2019s sarcoma. Int J Radiat Oncol Biol Phys 27: 1057\u20131061","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1223_CR26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.1998.16.2.683","volume":"16","author":"Stewart","year":"1998","unstructured":"Stewart S, Jablonowski H, Goebel FD et al. (1998) Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi\u2019s sarcoma. International Pegylated Liposomal Doxorubicin Study Group. J Clin Oncol 16: 683\u2013691","journal-title":"J Clin Oncol"},{"key":"1223_CR27","first-page":"43","volume":"10","author":"Tossing","year":"2005","unstructured":"Tossing G (2005) Management of chronic hepatitis C in HIV-co-infected patientes. Eur J Med Res 10: 43\u201345","journal-title":"Eur J Med Res"},{"key":"1223_CR28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/cncr.10634","volume":"95","author":"Tulpule","year":"2002","unstructured":"Tulpule A, Groopman J, Saville MW et al. (2002) Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi\u2019s sarcoma. Cancer 95: 147\u2013154","journal-title":"Cancer"},{"key":"1223_CR29","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/cncr.11775","volume":"15","author":"Vogt","year":"2003","unstructured":"Vogt T, Hafner C, Bross K (2003) Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors. Cancer 15: 2251\u20132256","journal-title":"Cancer"},{"key":"1223_CR30","first-page":"514","volume":"4","author":"Willers","year":"1999","unstructured":"Willers CP, Reiman G, Mertins L, Brockmeyer NH (1999) Influence of foscarnet on HIV-associated Kaposi\u2019s sarcoma derived cell lines. Eur J Med Res 4: 514\u2013516","journal-title":"Eur J Med Res"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-006-1223-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-006-1223-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-006-1223-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T03:37:12Z","timestamp":1558582632000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-006-1223-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["1223"],"URL":"https:\/\/doi.org\/10.1007\/s00105-006-1223-7","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}